What you should know before using Baqsimi Nasal Powder
Baqsimi should be used immediately when severe hypoglycemia is recognized. Signs of severe hypoglycemia include shakiness, dizziness, sweating, hunger, fast heartbeat, confusion, headache, or anxiety. Patients and caregivers should be aware of these symptoms.
In order to administer Baqsimi, insert the tip of the applicator into one nostril and press the plunger all the way until the green line is no longer showing. The patient does not need to inhale the dose. Each Baqsimi device contains only one dose of glucagon and therefore cannot be reused. After administering Baqsimi, the patient should consume some oral carbohydrates to prevent recurrence of hypoglycemia. Additionally, emergency assistance should be called after using Baqsimi. After 15 minutes, if there has been no response, patients can receive an additional dose of Baqsimi from a new device while waiting for emergency assistance.
Neither having a cold nor using a decongestant impacts the way Baqsimi works. Baqsimi should not be used in patients with pheochromocytoma, insulinoma, or known hypersensitivity to any of the ingredients.
There are several drug interactions in addition to the Baqsimi side effects that patients/caregivers should be aware of. Patients on beta-blockers, such as metoprolol, who receive Baqsimi may notice a temporary increase in blood pressure and heart rate. Baqsimi may increase the blood-thinning effects of warfarin and patients/caregivers should be cautious of increased bleeding. In patients taking indomethacin, Baqsimi may not work properly and patients could become even more hypoglycemic.